29 results
6-K
EX-99.3
LSB
LakeShore Biopharma Co., Ltd
7 May 24
Report of Foreign Private Issuer
4:30pm
and regulation demonstrate his commitment to advancing medical science and public health safety globally.
A-3
Dr. Xu earned his Bachelor of Medicine from
6-K
EX-99.4
LSB
LakeShore Biopharma Co., Ltd
14 Feb 24
Report of Foreign Private Issuer
8:05am
to vote at general meetings of the Company. Our commitment to YS is long-term, and we are eager to contribute our efforts and resources to enhance
6-K
EX-99.1
LSB
LakeShore Biopharma Co., Ltd
14 Feb 24
YS Biopharma Announces Appointment of New Directors
8:01am
, legal affairs, business management, and strategic decision-making. We expect that their diverse experience and commitment to success will serve our
POS AM
9587p62jpk1sg0iwrk3h
23 Jan 24
Prospectus update (post-effective amendment)
4:18pm
424B3
w2mmea8d8 a376
25 Sep 23
Prospectus supplement
6:12am
424B3
1lqlir kvz2u
25 Sep 23
Prospectus supplement
6:07am
6-K
EX-99.1
pmt5greg
25 Aug 23
YS Biopharma Announces Purchase of Shares by Company Officers
8:00am
6-K
EX-99.1
mthqmk il6
16 Aug 23
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
8:00am
424B3
q4e6 yjnc
15 Aug 23
Prospectus supplement
8:00am
POS AM
ep125ti40do9m73era7
8 Aug 23
Prospectus update (post-effective amendment)
4:06pm
20-F
t88bje 6f
26 Jul 23
Annual report (foreign)
4:02pm
424B3
tmcufn1
5 Jun 23
Prospectus supplement
4:03pm
F-1/A
f13ib95 njzxg
12 May 23
Registration statement (foreign) (amended)
4:05pm
F-1
gxear44n n151em1pu
12 Apr 23
Registration statement (foreign)
8:49am
F-4
EX-3.2
1occc je8g
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.11
hm5wzce cpjgcmnzkdm
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
1i13ta7yxb
28 Dec 22
Registration of securities (foreign)
6:58am
F-4
EX-10.9
42rd96
28 Dec 22
Registration of securities (foreign)
6:58am